A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
PHASE4
To demonstrate the efficacy of inhaled tiotropium + olodaterol via Respimat...
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
PHASE3
The primary objective of the trial is to determine the 24-hour FEV1-time pr...
Status
Completed
Location
1237.20.1204 Boehringer Ingelheim Investigational Site